Louis M Weiner

Louis M Weiner

UNVERIFIED PROFILE

Are you Louis M Weiner?   Register this Author

Register author
Louis M Weiner

Louis M Weiner

Publications by authors named "Louis M Weiner"

Are you Louis M Weiner?   Register this Author

97Publications

875Reads

-Profile Views

SpCas9-expression by tumor cells can cause T cell-dependent tumor rejection in immunocompetent mice.

Oncoimmunology 2019 16;8(5):e1577127. Epub 2019 Mar 16.

Department of Oncology and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2019.1577127DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492962PMC
March 2019

A Mechanism of Resistance to Antibody-Targeted Immune Attack.

Cancer Immunol Res 2019 Feb 18;7(2):230-243. Epub 2018 Dec 18.

Department of Oncology and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-18-0266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359950PMC
February 2019

Targeting Multiple Receptors to Increase Checkpoint Blockade Efficacy.

Int J Mol Sci 2019 Jan 4;20(1). Epub 2019 Jan 4.

Lombardi Comprehensive Cancer Center Chair, Department of Oncology, Georgetown University Medical Center, 3970 Reservoir Road NW Research Building E501, Washington, DC 20015, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20010158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337574PMC
January 2019

Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion.

Cancer Lett 2018 Aug 8;430:47-56. Epub 2018 May 8.

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03043835183032
Publisher Site
http://dx.doi.org/10.1016/j.canlet.2018.05.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004098PMC
August 2018

CancerInSilico: An R/Bioconductor package for combining mathematical and statistical modeling to simulate time course bulk and single cell gene expression data in cancer.

PLoS Comput Biol 2018 Jun 19;14(4):e1006935. Epub 2019 Apr 19.

Department of Oncology, Division of Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pcbi.1006935DOI Listing
June 2018

Plac1 Is a Key Regulator of the Inflammatory Response and Immune Tolerance In Mammary Tumorigenesis.

Sci Rep 2018 Apr 9;8(1):5717. Epub 2018 Apr 9.

Department of Oncology and Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, 20007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-24022-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890253PMC
April 2018

A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies.

Cancer Chemother Pharmacol 2018 03 1;81(3):587-596. Epub 2018 Feb 1.

Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-018-3533-8DOI Listing
March 2018

Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice.

Cancer Immunol Immunother 2018 02 17;67(2):195-207. Epub 2017 Oct 17.

Department of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-017-2077-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801048PMC
February 2018

An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejection.

Cancer Immunol Immunother 2017 Dec 2;66(12):1529-1544. Epub 2017 Aug 2.

Department of Oncology and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3970 Reservoir Road NW, Washington DC, 20057, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-017-2047-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854209PMC
December 2017

Protein network construction using reverse phase protein array data.

Methods 2017 07 24;124:89-99. Epub 2017 Jun 24.

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymeth.2017.06.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603262PMC
July 2017

Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma.

Am J Clin Oncol 2017 Apr;40(2):152-157

*Department of Radiation Oncology §Division of Gastroenterology, Department of Medicine ∥Department of Surgery, Georgetown University Hospital †Georgetown University School of Medicine ‡Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.

View Article

Download full-text PDF

Source
http://www.surgonc.org/docs/default-source/fellows-articles-
Web Search
http://pdfs.journals.lww.com/amjclinicaloncology/9000/00000/
Web Search
http://pancreas.imedpub.com/stereotactic-body-radiation-ther
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/COC.0000000000000118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418949PMC
April 2017

Predictive biomarkers for checkpoint inhibitor-based immunotherapy.

Lancet Oncol 2016 Dec;17(12):e542-e551

Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30406-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702534PMC
December 2016

Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer.

Cancer Chemother Pharmacol 2015 Dec 27;76(6):1309-14. Epub 2015 Oct 27.

Division of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3800 Reservoir Road, NW, Washington, DC, 20007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2855-zDOI Listing
December 2015

Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies.

Cancer Chemother Pharmacol 2015 May 20;75(5):1047-55. Epub 2015 Mar 20.

Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2705-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978949PMC
May 2015

Cancer immunology for the clinician.

Authors:
Louis M Weiner

Clin Adv Hematol Oncol 2015 May;13(5):299-306

Georgetown Lombardi Comprehensive Cancer Center, Washington, DC.

View Article

Download full-text PDF

Source
May 2015

Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2.

Cancer Cell 2015 Apr;27(4):489-501

Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2015.03.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398916PMC
April 2015

Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructs.

J Clin Pharmacol 2015 Mar;55 Suppl 3:S4-20

Georgetown Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University Medical Center, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcph.407DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340091PMC
March 2015

c-Abl modulates tumor cell sensitivity to antibody-dependent cellular cytotoxicity.

Cancer Immunol Res 2014 Dec 9;2(12):1186-98. Epub 2014 Oct 9.

Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258447PMC
December 2014

IL4 limits the efficacy of tumor-targeted antibody therapy in a murine model.

Cancer Immunol Res 2014 Nov 9;2(11):1103-12. Epub 2014 Sep 9.

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221424PMC
November 2014

The development of immunoconjugates for targeted cancer therapy.

Nat Rev Clin Oncol 2014 Nov 30;11(11):637-48. Epub 2014 Sep 30.

Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3970 Reservoir Road NW, Washington, DC 20057, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2014.159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700536PMC
November 2014

The clinical potential of targeted nanomedicine: delivering to cancer stem-like cells.

Mol Ther 2014 Feb 11;22(2):278-291. Epub 2013 Oct 11.

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mt.2013.231DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916038PMC
February 2014

Genome-wide multi-omics profiling of colorectal cancer identifies immune determinants strongly associated with relapse.

Front Genet 2013 20;4:236. Epub 2013 Nov 20.

Department of Oncology, Innovation Center for Biomedical Informatics, Georgetown University Medical Center Washington, DC, USA ; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center Washington DC, USA.

View Article

Download full-text PDF

Source
http://journal.frontiersin.org/article/10.3389/fgene.2013.00
Publisher Site
http://dx.doi.org/10.3389/fgene.2013.00236DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834519PMC
December 2013

Heterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cells.

Cancer Biother Radiopharm 2013 May 23;28(4):274-82. Epub 2013 Apr 23.

1 Section of Molecular Cancer Therapeutics, Therapeutic Radiology-Radiation Oncology, University of Minnesota Masonic Cancer Center , Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/cbr.2012.1329DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209492PMC
May 2013

Antibody-based immunotherapy of cancer.

Cell 2012 Mar;148(6):1081-4

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3800 Reservoir Road NW, Washington, DC 20007, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00928674120023
Publisher Site
http://dx.doi.org/10.1016/j.cell.2012.02.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310896PMC
March 2012

Tumor-cell death, autophagy, and immunity.

N Engl J Med 2012 Mar;366(12):1156-8

Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMcibr1114526DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389780PMC
March 2012

Monoclonal antibodies for the treatment of cancer.

Semin Cancer Biol 2012 Feb 8;22(1):3-13. Epub 2012 Jan 8.

Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2011.12.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288558PMC
February 2012

Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells.

Nat Rev Cancer 2011 Jun 16;11(7):523-32. Epub 2011 Jun 16.

Department of Biological Sciences, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc3081DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294292PMC
June 2011

Endoplasmic reticulum stress, the unfolded protein response, and gene network modeling in antiestrogen resistant breast cancer.

Horm Mol Biol Clin Investig 2011 Mar;5(1):35-44

Department of Oncology, Georgetown University School of Medicine, Washington, DC 20057, U.S.A. ; Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, DC 20057, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/hmbci.2010.073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734561PMC
March 2011

Monoclonal antibodies: versatile platforms for cancer immunotherapy.

Nat Rev Immunol 2010 May;10(5):317-27

Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nri2744DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508064PMC
May 2010

Vaccine prevention of cancer: can endogenous antigens be targeted?

Cancer Prev Res (Phila) 2010 Apr 23;3(4):410-5. Epub 2010 Mar 23.

Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3970 Reservoir Road Northwest, Washington, DC 20057, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-10-0040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853240PMC
April 2010

Mechanisms of tumor resistance to EGFR-targeted therapies.

Expert Opin Ther Targets 2009 Mar;13(3):339-62

Fox Chase Cancer Center, W462, 333 Cottman Ave., Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712590902735795 DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670612PMC
March 2009

Monoclonal antibodies for cancer immunotherapy.

Lancet 2009 Mar;373(9668):1033-40

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(09)60251-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677705PMC
March 2009

Cancer immunotherapy--the endgame begins.

Authors:
Louis M Weiner

N Engl J Med 2008 Jun;358(25):2664-5

Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp0803663DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728623PMC
June 2008

Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy.

J Immunol 2008 May;180(9):6392-401

Department of Medical Oncology and Division of Basic Science, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810560PMC
http://dx.doi.org/10.4049/jimmunol.180.9.6392DOI Listing
May 2008

Clinical utility of circulating tumor cells: a role for monitoring response to therapy and drug development.

Biomark Med 2008 Apr;2(2):137-45

Fox Chase Cancer Center, Department of Medical Oncology, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/17520363.2.2.137DOI Listing
April 2008

Monoclonal antibodies in therapy of solid tumors.

Surg Oncol Clin N Am 2007 Oct;16(4):775-92, viii

Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2007.07.001DOI Listing
October 2007

Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen.

J Immunol 2007 Sep;179(5):2815-23

Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.179.5.2815DOI Listing
September 2007

Building better magic bullets--improving unconjugated monoclonal antibody therapy for cancer.

Authors:
Louis M Weiner

Nat Rev Cancer 2007 09;7(9):701-6

Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19,111, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrc2209
Publisher Site
http://dx.doi.org/10.1038/nrc2209DOI Listing
September 2007

Targeted therapies in solid tumors: monoclonal antibodies and small molecules.

Hum Antibodies 2006 ;15(3):103-11

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
January 2007

Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors.

Cancer 2007 Jan;109(2):170-9

Clinical Hematology-Oncology, Centocor Research and Development, Inc., Malvern, Pennsylvania 19355, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22402DOI Listing
January 2007

Avidity-mediated enhancement of in vivo tumor targeting by single-chain Fv dimers.

Clin Cancer Res 2006 Mar;12(5):1599-605

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-2217DOI Listing
March 2006

Fully human therapeutic monoclonal antibodies.

Authors:
Louis M Weiner

J Immunother 2006 Jan-Feb;29(1):1-9

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.

View Article

Download full-text PDF

Source
February 2006

Isolation of scFvs to in vitro produced extracellular domains of EGFR family members.

Cancer Biother Radiopharm 2005 Dec;20(6):603-13

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/cbr.2005.20.603DOI Listing
December 2005

Overview of monoclonal antibodies and small molecules targeting the epidermal growth factor receptor pathway in colorectal cancer.

Clin Colorectal Cancer 2005 Nov;5 Suppl 2:S71-80

Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111-2412, USA.

View Article

Download full-text PDF

Source
November 2005

Monoclonal antibody therapy of cancer.

Nat Biotechnol 2005 Sep;23(9):1147-57

Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nbt1137
Publisher Site
http://dx.doi.org/10.1038/nbt1137DOI Listing
September 2005

Tunable antibodies.

Nat Biotechnol 2005 May;23(5):556-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nbt0505-556DOI Listing
May 2005

Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth.

Mol Cancer Ther 2005 Mar;4(3):351-60

Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111-2497, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-04-0269DOI Listing
March 2005

Bispecific minibodies targeting HER2/neu and CD16 exhibit improved tumor lysis when placed in a divalent tumor antigen binding format.

J Biol Chem 2004 Dec 7;279(52):53907-14. Epub 2004 Oct 7.

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M407888200DOI Listing
December 2004

Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer.

Cancer Chemother Pharmacol 2004 Jun 3;53(6):513-8. Epub 2004 Feb 3.

Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111-2497, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-004-0764-7DOI Listing
June 2004

Survival following intensive preoperative combined modality therapy with paclitaxel, cisplatin, 5-fluorouracil, and radiation in resectable esophageal carcinoma: a phase I report.

J Thorac Cardiovasc Surg 2003 Oct;126(4):1168-73

Fox Chase Cancer Center, Division of Thoracic Surgical Oncology, 7701 Burholme Ave, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0022DOI Listing
October 2003

Monoclonal antibody therapy for cancer.

Annu Rev Med 2003 3;54:343-69. Epub 2001 Dec 3.

Department of Medical Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, Pennsylvania 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev.med.54.101601.152442DOI Listing
June 2003

The rollercoaster ride to anti-cancer antibodies.

Nat Biotechnol 2003 May;21(5):510-1

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nbt0503-510DOI Listing
May 2003

Phase I and pharmacokinetic study of irinotecan in combination with raltitrexed.

Cancer Chemother Pharmacol 2002 Oct 21;50(4):257-65. Epub 2002 Aug 21.

Division of Medical Science, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-002-0500-0DOI Listing
October 2002

Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model.

Cancer Res 2002 Aug;62(16):4767-72

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.

View Article

Download full-text PDF

Source
August 2002

Beyond neutrophil recovery: manipulation of the tumor microenvironment by GM-CSF to control cancer.

Authors:
Louis M Weiner

Oncology (Williston Park) 2002 Jan;16(1 Suppl 1):7-9

Department of Medical Oncology Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
January 2002